盆腔器官脱垂修补术中网片植入的长期器械结局
这项基于纽约州2008至2016年人群的队列研究纳入54,194例盆腔器官脱垂修补术女性,其中网片组12,989例、非网片组41,205例,中位随访4.7年。倾向评分匹配后,网片修补与更高的再干预风险相关(HR 1.40,95%CI 1.27-1.54,P<.001),5年再干预风险网片组为8.8%、非网片组为6.3%;网片组再干预者中18.5%与网片相关并发症有关。结论强调即使经阴道网片已退市,网片并发症风险并未随时间降低,已植入女性需密切随访。
要点
- 网片修补组再干预风险显著高于非网片组(HR 1.40,95%CI 1.27-1.54)。
- 5年再干预风险网片组8.8%,非网片组6.3%。
- 网片组再干预者中18.5%与网片相关并发症有关。
核心结论
- 经阴道网片虽已退市,但网片并发症风险并未随时间降低,已植入女性需密切随访。
- 对盆腔器官脱垂修补术中网片的持续监测对已植入女性的安全至关重要。
研究设计与样本
- 基于纽约州2008至2016年住院和门诊手术人群的队列研究,纳入54,194例盆腔器官脱垂修补术女性。
- 采用多因素logistic回归基于患者和手术特征及医院手术量计算倾向评分,并进行时间-事件分析。
主要发现
- 倾向评分匹配12,284对女性后,网片修补与非网片修补相比再干预风险更高(HR 1.40,95%CI 1.27-1.54,P<.001)。
- 5年再干预估计风险网片组为8.8%(95%CI 8.2-9.3%),非网片组为6.3%(95%CI 5.9-6.8%)。
- 再干预患者中,网片手术者18.5%的再干预与网片相关并发症有关。
临床怎么用
- 对已植入网片行盆腔器官脱垂修补的女性应加强长期随访,警惕网片相关并发症及再干预风险。
- 临床决策时应告知患者网片修补相较非网片修补的再干预风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the longer-term safety and reintervention outcomes of mesh implants in pelvic organ prolapse (POP) repairs. METHODS: We conducted a population-based cohort study of women undergoing POP repairs in inpatient and outpatient surgical settings between 2008 and 2016 in New York State. Multivariable logistic regression was used based on patient and procedural characteristics and hospital volume between mesh and nonmesh groups to obtain propensity scores for each individual. Long-term safety events and reinterventions were assessed using time-to-event analysis. RESULTS: We identified 54,194 women undergoing POP repairs (12,989 with mesh, and 41,205 without mesh). Mean age was 59.8 (±13.1) years, and median follow-up was 4.7 years (interquartile range, 2.4-6.8 years). In the propensity score-matched 12,284 pairs of women, POP repair with mesh was associated with a higher risk of reintervention when compared with POP repair without transvaginal mesh (hazard ratio 1.40, 95% CI 1.27-1.54, P<.001). The estimated risk of undergoing a reintervention at 5 years was 8.8% (95% CI 8.2-9.3%) in the mesh group and 6.3% (5.9-6.8%) in the nonmesh group. Among patients who had reinterventions, 18.5% of those operated with mesh had a reintervention related to mesh-related complications. CONCLUSION: Even though transvaginal mesh has been removed from the market, the risk of mesh complications did not diminish over time and these women warrant close follow-up. Continued surveillance of mesh in POP repairs is essential to ensure safety for the women who have already been implanted.
引用
- Chughtai B, Mao J, Asfaw TS, et al. Long-term Device Outcomes of Mesh Implants in Pelvic Organ Prolapse Repairs. Obstet Gynecol. 2020. PMID: 32028486. doi:10.1097/AOG.0000000000003689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。